RePROM is a single centre randomised pilot trial of usual care supplemented with an electronic Patient-Reported Outcome Measure (ePROM) system in patients with advanced chronic kidney disease. This trial has now been completed.
Important Message: COVID-19
We are now home-based during the COVID-19 pandemic but available and working. Responses may however take longer than normal as staff may be working altered hours but we are cross covering trials as required and urgent matters will be dealt with promptly. Please do not contact our usual office/landline number and instead email the trial contact and copy in the trial mailbox. If a query requires a prompt response please mark as ‘urgent’ in the email subject header.
Trial details
Full Title: The use of an electronic Patient-Reported Outcome Measure in the Management of Patients with Advanced Chronic Kidney Disease (CKD).
Short Title: The RePROM Pilot Trial.
Aim of the study: To assess the feasibility of undertaking a randomised controlled trial (RCT) of the use of ePROMs in the management of advanced CKD.
Study design: Open-label randomised controlled pilot trial.
Sample size: 66 patients will be recruited over a 12-month period.
Study Duration: The accrual period is 1 year and all patients will be followed up for 12 months. The end of trial will be the date of the last data capture.
Timeframes: NIHR grant start date: 1st January 2017. Trial set up will take place over 12 months, recruitment will take 12 months, all patients will be followed up for 12 months and 6 months has been allocated for data analysis and report writing. We aim to recruit the first participant in April/May 2018.
Protocol publication: 'Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol' has now been published online by BMJ Open. Access the article for free at: http://bmjopen.bmj.com/cgi/content/full/bmjopen-2018-026080
______________________________________________________
Chief Investigator: Dr Derek Kyte
Trial E-mail: RePROM@trials.bham.ac.uk
Trial Sponsor: University of Birmingham. Ref.: RG_16-141.
Funding: National Institute for Health Research Post Doctoral Fellowship. Ref: PDF-2016-09-009.
Research Ethics Committee:West Midlands. Ref: 18/WM/0013. (approved 23 Feb 2018).
ISRCTN: ISRCTN12669006
NIHR CRN Study ID: 36497
IRAS project ID: 232960
Read the Trial Protocol
Read the trial contact details
The RePROM trial is a collaboration between Birmingham Clinical Trials Unit (BCTU) and the Centre for Patient Reported Outcome Research (CPROR).
